Pain management for sickle cell disease in children and adults

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 4, 2014, Pages

  Dunlop, Robert ^a   Bennett, Kyle C L B ^b  

^a InferMed Ltd   (United Kingdom)

^b Horatio Oduber Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL; RETRACTED ARTICLE; REVIEW; ACUTE DISEASE; ADULT; CHILD; CHRONIC DISEASE; COMPLICATION; HUMAN; META ANALYSIS; PAIN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SICKLE CELL ANEMIA;

CORTICOSTEROID; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHRONIC DISEASE; HUMANS; PAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84942780909     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003350.pub3     Document Type: Review

References (67)

1. Gonzalez ER, Ornato JP, Ware D, Bull D, Evens RP. Comparison of intramuscular analgesic activity of butorphanol and morphine in patients with sickle cell disease. Annals of Emergency Medicine 1989;18(5):603-5.
2. Griffin TC, McIntire D, Buchanan GR. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. NEJM 1994;330(11):733-7.
3. Grisham JE, Vichinsky EP. Ketorolac versus Meperidine in Vaso-Occlusive Crisis: A Study of Safety and Efficacy. International Journal of Pediatric Hematology / Oncology 1996;3:239-47.
4. Hardwick WE, Givens TG, Monroe KW, King WD, Lawley D. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis. Pediatric Emergency Care 1999;15(3):179-82.
5. Jacobson SJ, Kopechy EA, Joshi P, Babul N. Randomised trial of oral morphine for painful episodes of sickle-cell disease in children. Lancet 1997;350:1358-61.
6. Perlin E, Finke H, Castro O, Bang KM, Rana S, et al.Treatment of sickle cell pain crisis: A clinical trial of diflunisal (Dolobid). Clinical Trials Journal 1988;25(4):254-64.
7. Perlin E, Finke H, Castro O, Rana S, Pittman J, et al.Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis. American Journal of Hematology 1994;46:43-7.
8. Rogers ZR, Dale JC, Bernini JC, Reisch JS, Primm PA, et al.Dexamethasone shortens the duration of painful events requiring hospitalization in children with sickle cell disease: Results of a randomized, double-blind, placebo-controlled trial. Blood 1996;88:250a.
9. Wang WC, George SL, Wilimas JA. Transcutaneous electrical nerve stimulation treatment of sickle cell pain crises. Acta heamat 1988;80:99-102.
10. Wright SW, Norris RL, Mitchell TR. Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: Lack of a narcotic-sparing effect. Annals of Emergency Medicine 1992;21:925-8.
11. Anonymous. Clinical trials of therapy for sickle cell vaso-occlusive crises. JAMA 1974;228(9):1120-4.
12. Ballas SK, et al.Narcotic analgesic use among adult patients with sickle cell anemia. Blood 1995;86 suppl1):642a.
13. Barnes PM. Treatment of painful sickle cell crises: assessment of new methods. Clinical Pediatrics 1966;5(11):650-1.
14. Benjamin LJ. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises in SCD. Blood 2000;95:1130-6.
15. Beyer JE. Judging the effectiveness of analgesia for children and adolescent during vaso-occlusive events of sickle cell disease. J of Pain & Symptom Management 2000;19(1):63-72.
16. Brookoff D. Treating sickle cell pain like cancer pain. Annals of Internal Medicine 1992;116(5):364-8.
17. Fournier-Charriere E. Pain due to sickle cell crisis in pediatric patients: semiology, evaluation and treatment. Annales de Pediatrie 1995;42(2):105-14.
18. Christensen ML. Transdermal fentanyl administration in children and adolescents with SCDC. Journal of Pediatric Hematology/Oncology 1996;18(4):372-6.
19. Co LL, Schmitz TH, Havdala H, Reyes A, Westerman MP. Acupuncture: An evaluation in the painful crises of sickle cell anaemia. Pain 1979;7:181-5.
20. Cole TB, Sprinkle RH, Smith SJ, Buchanan GR. Intravenous narcotic therapy for children with severe sickle cell pain crisis. American Journal of Diseases of Children 1986;140(12):1255-9.
21. Conner-Warren RL. Pain intensity and home pain management of children with sickle cell. Ped Nursing 1996;19(3):183-95.
22. Conti C. Oral morphine protocol for sickle cell crisis pain. Maryland Medical Journal 1996;45(1):33-5.
23. Crockett RK. Pain management in the pediatric emergency department. International Pediatrics 1989;4(1):14-8.
24. Dampier CD. Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease. J of Ped 1995;126:461-7.
25. De Ceulaer K, Gruber C, et al.Medroxyprogesterone acetate and homozygous sickle cell disease. Lancet 1982;2:229-31.
26. Eke FU. Dispensable piroxican versus acethylsalicyl for the treatment of osteoarticulair pan attack in SCD crisis. Tropical Medicine & International Health 2000;5(2):81-4.
27. Friedman EW, Webber AB, Osborn HH, Schwartz S. Oral analgesia for treatment of painful crisis in sickle cell anemia. Annals of Emergency Medicine 1986;15(7):787-91.
28. Gbadoe AD, Atakouma DY, Akoli A, Assimadi JK. Home care of vaso-occlusive crisis in sickle cell disease in Togo. Archives de Pediatrie 1999;6(9):958-61.
29. Gevirtz CM. Pediatric pain management. Progress of Anesthesiology 1996;10(5):75-88.
30. Gonzalez ER. Intermittent injection versus patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department. Arch of Internal Med 1991;151(7):1373-8.
31. Holbrook CT. Patient-controlled analgesia pain management for children with sickle cell disease. J of the Ass for Academic Minority Physician 1990;1(3):93-6.
32. Howland MA. Meperidine usage in patients with sickle cell crises. Annals of Emergency Medicine 1986;15(12):1506-8.
33. Juneja HS. Pathophysiology and management of sickle cell pain crisis. Lancet 1995;346(8987):1408-11.
34. Koshy M, Burd L, et al.Prophylactic red cell transfusions in pregnant patients with sickle cell disease. A randomised cooperative study. NEJM 1988;320:1286-7.
35. McPherson E. Patient-controlled analgesia in patients with sickle cell vaso-occlusive crisis. American Journal of the Medical Sciences 1990;299(1):10-2.
36. Morrison RA, Vedro DA. Pain management in the child with sickle cell disease. Pediatric Nursing 1989;15(6):595-9.
37. Perlin E. Infusional / patient controlled analgesia in sickle cell vaso-occlusive crises. Pain Clin 1993;6(2):113-9.
38. Rabb L, Grandison Y, et al.A trial of folate supplementation in children with homozygous sickle cell disease. British Journal of Haematology 1983;54:589-94.
39. Robieux IC. Analgesia in children with sickle cell crisis: comparison of intermittent opioids versus continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation. Pediatric Hematology & Oncology 1992;9(4):317-26.
40. Sangare A. Intramuscular piroxicam treatment of painful articular attacks in sickle cell disease. A pilot study. Current Therapeutic Research Clinical & Experimental 1990;47(3):597-604.
41. Sangare A. Treatment results of ketoprofen (prefenid) in the treatment of painful crises in sickle cell anemia. Medecine D'Afrique Noire 1990;37(11):693-9.
42. Sangare A. The treatment of drepanocytary vasoocclusive pain with intramuscular ketoprofen followed by an oral form of the drug. Medecine D'Afrique Noire 1992;39(1):74-7.
43. Sangare A. An open comparative study of parenteral piroxicam and parenteral lysine acetylsalicylate in the treatment of acute painful articular attacks of SCD. Current Therapeutic Research Clinical and Experimental 1993;54(5):544-9.
44. Schechter NL. Pain and pain control in children. Curr Probl Pediatr 1985;15(5):1-67.
45. Schechter NL, Berrien FB, Katz SM. The use of patient-controlled analgesia in adolescents with sickle cell pain crisis: a preliminary report. J Pain Symptom Manage 1988;3(2):109-13.
46. Serjeant GR, Ceulaer CDE, Lethbridge R, Morris J, et al.The painful crisis of homozygous sickle cell disease: clinical features. British Journal of Haematology 1994;87(3):586-91.
47. Shapiro BS. Patient-controlled analgesia for sickle-cell-related pain. Journal of Pain & Symptom Management 1993;8(1):22-8.
48. Silbergleit R. Management of sickle cell pain crisis in the emergency department at a teaching hospital. J of Emergency Med 1999;17(4):625-30.
49. Teresi ME, Wicklund BM, et al.Comparison of controlled release oral morphine to continuous intravenous morphine infusion in the control of pain in sickle cell crisis. J Pain Symptom Management 1991;6:58.
50. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, et al.Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J of Med 2000;342(25):1855-65.
51. Wethers DL, Ramirez GM, et al.Accelerated healing of chronic sickle-cell leg ulcers treated with RGB peptide matrix. Blood 1994;84:1775-9.
52. Woods GM, Parson PM, Strickland DK. WoWoods GM, Parson PM, Strickland DK. Efficacy of nalbuphine as a parenteral analgesic for the treatment of painful episodes in children with sickle cell disease. J Assoc Acad Minor Phys 1990;1(3):90-2.
53. Yaster M. Epidural analgesia in the management of severe vaso-occlusive sickle. Pediatrics 1994;93(2):310-5.
54. Zago MA, Costa FF, et al.Treatment of sickle cell diseases with aspirin. Acta Haematol Basel 1984;72:61-4.
55. Ballas SK. Sickle cell disease: Clinical management. Ballieres Clinical Haematology 1998;11:185-214.
56. Brozovic M, Davies SC, Brownell AI. Acute admissions of patients with sickle cell disease who live in Britain. BMJ 1987;294:1206-8.
57. Charache S. Terrin ML. Moore RD. Dover GJ. Barton FB. Eckert SV. McMahon RP. Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. NEJM 1995;332(20):1317-22.
58. Clelland CS, Gonin R, Hatfield AK, et al.Pain and pain treatment in outpatients with metastatic cancer: The Eastern Co-operative Oncology Group's Out-patient Pain Study. NEJM 1994;331:592-6.
59. Davies S, Olujohungbe A, Jones AP. Hydroxyurea for sickle cell disease. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI:].
60. Grabinski PY, Kaiko RF, Rogers AG, Houde RW. Plasma levels and analgesia following deltoid and gluteal injections of methadone and morphine. Journal of Clinical Pharmacology 1983;23(1):48-55.
61. Jadad AR, Moore RA, Carroll D, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
62. Justins DM, Richardson PH. Clinical management of acute pain. British Medical Bulletin 1991;47:561-83.
63. McQuay H, Moore A. An Evidence-based Resource for Pain Relief. 1st Edition. Bath: Oxford University Press, 1999. [: ISBN 0 19 263048 2].
64. Platt OS, Thorington BD, Brambilla DJ, Milner PF, et al.Pain in sickle cell disease. NEJM 1991;325:11-6.
65. Sawe J, Dahlstrom B, Rane A. Steady-state kinetics and analgesic effect of oral morphine in cancer patients. European Journal of Clinical Pharmacology 1983;24(4):537-42.
66. Szeto HH, Interussi CE, Houde R, Saal S, et al.Accumulation of norperidine, an active metabolite of meperidine, in patients with renal failure or cancer. Annals of Internal Medicine 1977;86:738-41.
67. Vijay V, Cavenagh JD, Yate P. The anaesthetist's role in acute sickle cell crisis. British Journal of Anaesthesia 1998;80(6):820-8.